SCHEMBL21362725

SCHEMBL21362725

COC(=O)C(CCCl)NC(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.52
RAB9A P51151 1/20 0.52
ALDH1A1 P00352 2/20 0.51
LMNA P02545 2/20 0.51
GLA P06280 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
TAS1R3 Q7RTX0 6/20 0.49
TAS1R1 Q7RTX1 6/20 0.49
CYP26A1 O43174 1/20 0.48
CTSL P07711 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.46
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
PADI6 Q6TGC4 1/20 0.46
PADI1 Q9ULC6 1/20 0.46
PADI3 Q9ULW8 1/20 0.46
PADI4 Q9UM07 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24950469 0.88 BCHE (0.51) GAARAB9ALMNACYP26A1CTSL
SCHEMBL24924116 0.88 BCHE (0.51) GAARAB9ALMNACYP26A1CTSL
SCHEMBL8235468 0.88 CA1 (0.56) GAARAB9AALDH1A1LMNAGLA
SCHEMBL14535743 0.88 GAA (0.54) GAARAB9AALDH1A1LMNAGLA
SCHEMBL712639 0.86 TAS1R3 (0.60) GAARAB9AALDH1A1LMNAGLA
SCHEMBL714905 0.86 TAS1R3 (0.60) GAARAB9AALDH1A1LMNAGLA
SCHEMBL12158277 0.85 LMNA (0.61) GAARAB9AALDH1A1LMNAGLA
SCHEMBL8234956 0.85 TAS1R3 (0.52) GAARAB9AALDH1A1LMNAGLA
SCHEMBL16359991 0.85 TAS1R3 (0.52) GAARAB9AALDH1A1LMNAGLA
SCHEMBL27660162 0.84 ALOX5 (0.52) GAARAB9AALDH1A1LMNAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020046403-A1 NOVEL PROCESS FOR THE PREPARATION OF ENANTIOPURE 3- ENANTIOPURE 3-AMINO TETRAHYDROFURAN AND ITS SALTS MAJEED MUHAMMED (US) 2020-03-05 WO disclosed
US-10421734-B1 Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts SAMI LABS LIMITED (IN) 2019-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10421734-B1 Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts AASDHPPT, AAAS, AADAT GAA 4084/4885RAB9A 2239/4885ALDH1A1 538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.